Atossa Therapeutics (ATOS) Q2 2024 Earnings

13MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.08
-0.07
-0.06
-0.05

Details

Expected EPS
-0.066667
Actual EPS
-0.05
Surprise EPS
0.02
Surprise Percent
+25%

Description

Atossa Therapeutics (ATOS) has reported earnings of -0.05 per share for Q2 2024.

0 Comments

Share your thoughts